Jade Pattyn , Nikita Hanning , Sara Valckx , Toni Claessens , Emilie Karafillakis , Veerle Jong , Heidi Theeten , Greet Hendrickx , Pierre Van Damme
{"title":"调查法兰德斯(比利时)普通公众和13岁以下儿童父母对疫苗的信心状况","authors":"Jade Pattyn , Nikita Hanning , Sara Valckx , Toni Claessens , Emilie Karafillakis , Veerle Jong , Heidi Theeten , Greet Hendrickx , Pierre Van Damme","doi":"10.1016/j.vaccine.2025.127250","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>The aim of this study was to explore vaccine confidence, a factor influencing vaccination uptake, in Flanders (Belgium) during November 2023. The study evaluated confidence in vaccines generally and in specific vaccines: MMR, HPV, seasonal influenza, and COVID-19.</div></div><div><h3>Methods</h3><div>This cross-sectional study surveyed 1500 individuals: 1000 from the general population (>18 years) and 500 parents with children (≤13 years). Vaccine confidence was measured using the Vaccine Confidence Index™ (VCI). Weighted analysis and multivariable binary logistic regressions were employed to explore the association between sociodemographic and other potential predictors influencing vaccine confidence.</div></div><div><h3>Results</h3><div>The results showed that 77.9 % (CI 75.0–80.8) of the general population and 81.6 % (CI 76.5–86.6) of parents considered vaccines to be generally safe, while >80 % of both groups saw them as effective and important for children. A total of 56.9 % (CI 53.2–60.6) of the general population and 64.5 % (CI 54.5–74.5) of the parents agreed that vaccines are important, safe, effective, and compatible with their beliefs. Lower VCI scores were observed for COVID-19 (52.1 % (CI 48.2–55.9)) and HPV vaccines (56.2 % (CI 52.2–60.2)) in the general population, and for COVID-19 (50.2 % (CI 39.4–61.0)) and influenza vaccines (61.7 % (CI 51.5–72.0)) among parents. Higher VCI scores were observed in older generations (>45 years) and higher-educated individuals.</div></div><div><h3>Conclusion</h3><div>Most participants are confident in vaccines. While quantitative monitoring has been conducted across Europe, including in Belgium, this monitoring study focuses on Flanders, providing a valuable baseline for future reference. Longitudinal research, preferably including also qualitative research, is needed to further understand trends and how to build and sustain confidence in Flanders.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"58 ","pages":"Article 127250"},"PeriodicalIF":4.5000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Investigating the state of vaccine confidence among the general public and parents with children up to 13 years in Flanders (Belgium)\",\"authors\":\"Jade Pattyn , Nikita Hanning , Sara Valckx , Toni Claessens , Emilie Karafillakis , Veerle Jong , Heidi Theeten , Greet Hendrickx , Pierre Van Damme\",\"doi\":\"10.1016/j.vaccine.2025.127250\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><div>The aim of this study was to explore vaccine confidence, a factor influencing vaccination uptake, in Flanders (Belgium) during November 2023. The study evaluated confidence in vaccines generally and in specific vaccines: MMR, HPV, seasonal influenza, and COVID-19.</div></div><div><h3>Methods</h3><div>This cross-sectional study surveyed 1500 individuals: 1000 from the general population (>18 years) and 500 parents with children (≤13 years). Vaccine confidence was measured using the Vaccine Confidence Index™ (VCI). Weighted analysis and multivariable binary logistic regressions were employed to explore the association between sociodemographic and other potential predictors influencing vaccine confidence.</div></div><div><h3>Results</h3><div>The results showed that 77.9 % (CI 75.0–80.8) of the general population and 81.6 % (CI 76.5–86.6) of parents considered vaccines to be generally safe, while >80 % of both groups saw them as effective and important for children. A total of 56.9 % (CI 53.2–60.6) of the general population and 64.5 % (CI 54.5–74.5) of the parents agreed that vaccines are important, safe, effective, and compatible with their beliefs. Lower VCI scores were observed for COVID-19 (52.1 % (CI 48.2–55.9)) and HPV vaccines (56.2 % (CI 52.2–60.2)) in the general population, and for COVID-19 (50.2 % (CI 39.4–61.0)) and influenza vaccines (61.7 % (CI 51.5–72.0)) among parents. Higher VCI scores were observed in older generations (>45 years) and higher-educated individuals.</div></div><div><h3>Conclusion</h3><div>Most participants are confident in vaccines. While quantitative monitoring has been conducted across Europe, including in Belgium, this monitoring study focuses on Flanders, providing a valuable baseline for future reference. Longitudinal research, preferably including also qualitative research, is needed to further understand trends and how to build and sustain confidence in Flanders.</div></div>\",\"PeriodicalId\":23491,\"journal\":{\"name\":\"Vaccine\",\"volume\":\"58 \",\"pages\":\"Article 127250\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0264410X2500547X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X2500547X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Investigating the state of vaccine confidence among the general public and parents with children up to 13 years in Flanders (Belgium)
Aim
The aim of this study was to explore vaccine confidence, a factor influencing vaccination uptake, in Flanders (Belgium) during November 2023. The study evaluated confidence in vaccines generally and in specific vaccines: MMR, HPV, seasonal influenza, and COVID-19.
Methods
This cross-sectional study surveyed 1500 individuals: 1000 from the general population (>18 years) and 500 parents with children (≤13 years). Vaccine confidence was measured using the Vaccine Confidence Index™ (VCI). Weighted analysis and multivariable binary logistic regressions were employed to explore the association between sociodemographic and other potential predictors influencing vaccine confidence.
Results
The results showed that 77.9 % (CI 75.0–80.8) of the general population and 81.6 % (CI 76.5–86.6) of parents considered vaccines to be generally safe, while >80 % of both groups saw them as effective and important for children. A total of 56.9 % (CI 53.2–60.6) of the general population and 64.5 % (CI 54.5–74.5) of the parents agreed that vaccines are important, safe, effective, and compatible with their beliefs. Lower VCI scores were observed for COVID-19 (52.1 % (CI 48.2–55.9)) and HPV vaccines (56.2 % (CI 52.2–60.2)) in the general population, and for COVID-19 (50.2 % (CI 39.4–61.0)) and influenza vaccines (61.7 % (CI 51.5–72.0)) among parents. Higher VCI scores were observed in older generations (>45 years) and higher-educated individuals.
Conclusion
Most participants are confident in vaccines. While quantitative monitoring has been conducted across Europe, including in Belgium, this monitoring study focuses on Flanders, providing a valuable baseline for future reference. Longitudinal research, preferably including also qualitative research, is needed to further understand trends and how to build and sustain confidence in Flanders.
期刊介绍:
Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.